Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI864299Aexternal-prioritypatent/FI87457C/en
Application filed by Dainippon Pharmaceutical CofiledCriticalDainippon Pharmaceutical Co
Publication of FI922482A0publicationCriticalpatent/FI922482A0/en
Publication of FI922482ApublicationCriticalpatent/FI922482A/en
Publication of FI89797BpublicationCriticalpatent/FI89797B/en
Application grantedgrantedCritical
Publication of FI89797CpublicationCriticalpatent/FI89797C/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
The invention relates to the production of new quinoline compounds with formula I, and esters and pharmaceutically acceptable acid addition salts thereof, <IMAGE> in which formula R1, R2 and R3 are identical or different and denote hydrogen or methyl. These compounds have antibacterial effect.
FI922482A1985-10-291992-05-29
EXTERNAL FRAMEWORK FOR THERAPEUTIC USE OF THERAPEUTIC 7-SUBSTITUTES
FI89797C
(en)